Application of hydrogen bonding calculations in property based drug design

Drug Discovery Today

Volumn 7, Issue 20, 2002, Pages 1056-1063

  Abraham, Michael H ^a   Ibrahim, Adam ^a   Zissimos, Andreas M ^a   Zhao, Yuan H ^a   Comer, John ^b   Reynolds, Derek P ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Sirius Analytical Instruments Ltd   (United Kingdom)

^c Reytek Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ACIDITY; ALKALINITY; BRAIN PERFUSION; CALCULATION; DATA BASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TRANSPORT; GASTROINTESTINAL ABSORPTION; HYDROGEN BOND; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; QUALITATIVE ANALYSIS; REVIEW; SOLVATION;

ANIMALS; DRUG DESIGN; HUMANS; HYDROGEN BONDING; PHARMACEUTICAL PREPARATIONS;

EID: 0037107985     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02478-9     Document Type: Review

References (52)

1. Hodgson J. ADMET- turning chemicals into drugs. Nat. Biotechnol. 19:2001;722-726.
2. Baxter A.D., Lockey P.M. Hit' to 'lead' and 'lead' to 'candidate' optimisation using multi-parametric principles. Drug Discov. World. 3:2001;9-15.
3. Van de Waterbeemd H., et al. Property-based design: optimisation of drug absorption and pharmacokinetics. J. Med. Chem. 44:2001;1313-1333.
4. Amidon G.L., et al. Theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:1995;413-420.
5. Van de Waterbeemd H. The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. Eur. J. Pharm. Sci. 7:1998;1-3.
6. Van de Waterbeemd H., Testa B. The parametrization of lipophilicity and other properties in drug design. Adv. Drug Res. 16:1987;85-225.
7. El-Tayar A., et al. Polar intermolecular interactions encoded in partition coefficients: an indirect estimation of hydrogen-bond parameters of polyfunctional solutes. J. Phys. Chem. 96:1992;1455-1459.
8. Abraham M.H. Scales of hydrogen bonding - their construction and application to physicochemical and biochemical processes. Chem. Soc. Rev. 22:1993;73-83.
9. Platts J.A., et al. Estimation of molecular linear free energy relationship descriptors by a group contribution approach. 2. Prediction of partition coefficients. J. Chem. Inf. Comput. Sci. 40:2000;71-80.
10. Clark D.E., Pickett S.D. Computational methods for the prediction of 'drug-likeness'. Drug Discov. Today. 5:2000;49-58.
11. Raevsky O.A., Schaper K.J. Quantitative estimation of hydrogen bond contribution to permeability and absorption processes of some chemicals and drugs. Eur. J. Med. Chem. 33:1998;799-807.
12. Zhao Y.H., et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 90:2001;749-784.
13. Platts J.A., et al. Estimation of molecular linear free energy relationship descriptors. 4. Correlation and prediction of cell permeation. Pharm. Res. 17:2000;1013-1018.
14. Osterberg T., Norinder U. Prediction of polar surface area and drug transport processes using simple parameters and PLS statistics. J. Chem. Inf. Comput. Sci. 40:2000;1408-1411.
15. Lipinski C.A., et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:1997;3-25.
16. Ghose A.K., et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem. 1:1999;55-68.
17. Oprea T.L. Property distribution of drug-related chemical databases. J. Comput. Aided Mol. Des. 14:2000;251-264.
18. Hann M.M., et al. Molecular complexity and its impact on the probability of finding leads for drugdiscovery. J. Chem. Inf. Comput. Sci. 41:2001;856-864.
19. Oprea T.I., et al. Is There a difference between leads and drugs? A historical perspective. J. Chem. Inf. Comput. Sci. 41:2001;1308-1315.
20. Norinder U., Osterberg T. The applicability of computational chemistry in the evaluation and prediction of drug transport properties. Perspect. Drug Discov. Des. 19:2000;1-18.
21. Palm K., et al. Evaluation of dynamic polar molecular surface area as a predictor of drug absorption: comparison with other computational and experimental properties. J. Med. Chem. 41:1998;5382-5392.
22. Clark D.E. Rapid evaluation of polar surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J. Pharm. Sci. 88:1999;807-814.
23. Winiwater S., et al. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J. Med. Chem. 41:1998;4938-4949.
24. Norinder U., et al. Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. Eur. J. Pharm. Sci. 88:1999;807-814.
25. Oprea T.J., Gottfries J. Towards minimalistic modelling of oral drug absorption. J. Mol. Graph. Model. 17:2000;261-274.
26. Wessel M.D., et al. Prediction of human intestinal absorption of drug compounds from molecular structure. J. Chem. Inf. Comput. Sci. 38:1998;726-735.
27. Zhao Y.H., et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 90:2001;749-784.
28. Van de Waterbeemd H., et al. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug Target. 2:1998;151-165.
29. Clark D.E. Rapid calculation of polar surface area and its application to the prediction of transport phenomena. 2. Prediction of blood brain barrier penetration. J. Pharm. Sci. 88:1999;815-821.
30. Norinder U., et al. Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics. J. Pharm. Sci. 87:1998;952-959.
31. Kelder J., et al. Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm. Res. 16:1999;1514-1519.
32. Crivori P., et al. Predicting blood-brain barrier permeation from three-dimensional molecular structure. J. Med. Chem. 43:2000;2204-2216.
33. Platts J.A., et al. Correlation and prediction of a large blood-brain distribution set - an LFER study. Eur. J. Med. Chem. 36:2001;719-730.
34. Cronin M.T.D., et al. Investigation of the mechanism of flux across human skin in vitro in quantitative structure-permeability relationships. Eur. J. Pharm. Sci. 7:1999;325-330.
35. Potts R.O., Guy R.H. A predictive algorithm for skin permeability: The effects of molecular size and hydrogen bond activity. Pharm. Res. 12:1995;1628-1633.
36. Pugh W.J., et al. Epidermal permeability penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge. Int. J. Pharm. 197:2000;203-211.
37. Abraham M.H., et al. Algorithms for skin permeability using hydrogen bond descriptors: the problem of steroids. J. Pharm. Pharmacol. 49:1997;858-865.
38. Prausnitz M.R., Noonan J.S. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J. Pharm. Sci. 87:1998;1479-1488.
39. Raevsky O.A. Hydrogen Bond Strength Estimation by means of HYBOT. Waterbeemd H., et al. Computer-Assisted Lead Finding and Optimisation. 1997;367-378 Verlag, Basel.
40. Abraham M.H., Platts J.A. Hydrogen bond structural group constants. J. Org. Chem. 66:2001;3484-3491.
41. oct: a tool for lipophilicity determination in drug discovery. J. Med. Chem. 43:2000;2922-2928.
42. Du C.M., et al. Characterising the selectivity of stationary phases and organic modifiers in reversed-phase high-performance liquid chromatographic systems by a general solvation equation using gradient elution. J. Chromatogr. Sci. 38:2000;503-511.
43. Zissimos, A.M. et al. A comparison between the two general sets of linear free energy descriptors of Abraham and Klamt. J. Chem. Inf. Comput. Sci. (in press)
44. Zissimos A.M., et al. Calculation of Abraham descriptors from solvent-water partition coefficients in four different systems; evaluation of different methods of calculation. J. Chem. Soc. Perkin Trans. 2:2002;470-477.
45. Platts J.A., et al. Estimation of molecular linear free energy relation descriptors by a group contribution approach. J. Chem. Inf. Comput. Sci. 39:1999;835-845.
46. Abraham M.H., et al. Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. J. Pharm. Sci. 83:1994;1450-1456.
47. Ertl P., et al. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 43:2000;3714-3717.
48. Gratton J.A., et al. Molecular factors influencing drug transfer across the blood brain barrier. J. Pharm. Pharmacol. 49:1997;1211-1216.
49. Abraham M.H., Le J. The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship. J. Pharm. Sci. 88:1999;868-880.
50. Abraham M.H., et al. On the mechanism of human intestinal absorption. Eur. J. Med. Chem. 37:2002;595-605.
51. Veber D.F., et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45:2002;2615-2623.
52. Japertas P., et al. Fragmental methods in the design of new compounds. Applications of the algorithm builder. Quant. Struct. Act. Relation. 21:2002;23-37.